Package 0093-2179-01

Brand: liothyronine sodium

Generic: liothyronine sodium
NDC Package

Package Facts

Identity

Package NDC 0093-2179-01
Digits Only 0093217901
Product NDC 0093-2179
Description

100 TABLET in 1 BOTTLE (0093-2179-01)

Marketing

Marketing Status
Marketed Since 2021-02-26
Brand liothyronine sodium
Generic liothyronine sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "22ed1e76-c20a-481e-bc00-2b531d14c3e4", "openfda": {"upc": ["0300932180017", "0300932178014"], "unii": ["GCA9VV7D2N"], "rxcui": ["903456", "903697", "903703"], "spl_set_id": ["548d684a-86f5-4e57-9844-d8cf0a84e068"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0093-2179-01)", "package_ndc": "0093-2179-01", "marketing_start_date": "20210226"}], "brand_name": "Liothyronine Sodium", "product_id": "0093-2179_22ed1e76-c20a-481e-bc00-2b531d14c3e4", "dosage_form": "TABLET", "pharm_class": ["Triiodothyronine [CS]", "l-Triiodothyronine [EPC]"], "product_ndc": "0093-2179", "generic_name": "Liothyronine Sodium", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Liothyronine Sodium", "active_ingredients": [{"name": "LIOTHYRONINE SODIUM", "strength": "5 ug/1"}], "application_number": "ANDA211510", "marketing_category": "ANDA", "marketing_start_date": "20210226", "listing_expiration_date": "20261231"}